USE OF AUTOLOGOUS EFFECTOR CELLS AND ANTIBODIES FOR TREATMENT OF MULTIPLE MYELOMA

• 收藏
• 分享

专利权人:

Frits Van Rhee

发明人:

Frits Van Rhee

申请号：

US13505005

公开号：

US20130058921A1

申请日:

2009.10.30

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present disclosure provides methods for treating multiple myeloma using a combination of autologous expanded and activated NK cells from the patient and an antibody that targets an antigen on myeloma cells and/or an antibody that targets the KIR antigen on NK cells, wherein the antibodies elicit ADCC toward myeloma cells. The present disclosure provides methods for treating multiple myeloma using a combination of autologous NK cells and the anti-CS1 antibody elotuzumab.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/